Solid Dose: Under-hyped but not under-represented
The buzz may be around biologics, but the oral solid dose sector is still going strong
By Karen Langhauser, Chief Content Director - Jun 13, 2019 - pharmamanufacturing.com
Tablets may not be as glamorous or cutting-edge as emerging sectors of the biologics markets, but they have their upsides.…
Read More...
Read More...